KOC
AMGN icon

Koss-Olinger Consulting’s Amgen AMGN Stock Holding History

Koss-Olinger Consulting’s Portfolio AMGN Stock Details AMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-4,185
Closed -$1.17M – 271
2025
Q3 		$1.17M Sell
4,185
-16
-0.4% -$4.64K 0.1% 109
2025
Q2 		$1.17M Sell
4,201
-28
-0.7% -$7.93K 0.1% 110
2025
Q1 		$1.32M Buy
+4,229
New +$1.25M 0.11% 100
2024
Q2 		– Sell
-3,736
Closed -$1.06M – 270
2024
Q1 		$1.06M Buy
+3,736
New +$1.09M 0.57% 34
2021
Q3 		– Sell
-2,867
Closed -$699K – 233
2021
Q2 		$699K Buy
2,867
+111
+4% +$27.3K 0.1% 110
2021
Q1 		$686K Buy
+2,756
New +$658K 0.12% 101

Other funds holding AMGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Koss-Olinger Consulting's AMGN Position: Q4 2025 in Review

Koss-Olinger Consulting sold out of Amgen (AMGN) in Q4 2025, closing a stake of 4,185 shares — an estimated $1.17M sold.

Koss-Olinger Consulting first reported a position in AMGN in Q1 2021 and held it in 6 quarters. The position peaked at $1.32M in Q1 2025. 3,091 funds tracked by Wall St. Rank hold AMGN as of Q4 2025.

  • Koss-Olinger Consulting reported no remaining Amgen position as of Q4 2025 after selling out during the quarter.
  • Koss-Olinger Consulting sold 4,185 Amgen shares in Q4 2025, an estimated $1.17M.
  • Koss-Olinger Consulting first reported a position in Amgen in Q1 2021 and held it in 6 quarters.
  • Koss-Olinger Consulting's Amgen position peaked at $1.32M in Q1 2025.
  • 3,091 funds tracked by Wall St. Rank held Amgen as of Q4 2025.

Based on Koss-Olinger Consulting's 13F filing for Q4 2025, filed 10 Feb 2026.